These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19709354)

  • 1. Dacarbazine as single-agent therapy for relapsed lymphoma in dogs.
    Griessmayr PC; Payne SE; Winter JE; Barber LG; Shofer FS
    J Vet Intern Med; 2009; 23(6):1227-31. PubMed ID: 19709354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of CCNU and DTIC chemotherapy for treatment of resistant lymphoma in dogs.
    Flory AB; Rassnick KM; Al-Sarraf R; Bailey DB; Balkman CE; Kiselow MA; Autio K
    J Vet Intern Med; 2008; 22(1):164-71. PubMed ID: 18289305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Tolerability of Combination Chemotherapy with Mitoxantrone and Dacarbazine in Dogs with Lymphoma.
    Intile JL; Rassnick KM; Al-Sarraf R; Chretin JD
    J Am Anim Hosp Assoc; 2019; 55(2):101-109. PubMed ID: 30653362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dacarbazine as single-agent therapy for relapsed lymphoma in dogs.
    Dervisis NG; Kitchell BE
    J Vet Intern Med; 2010; 24(1):4; author reply 5. PubMed ID: 20391633
    [No Abstract]   [Full Text] [Related]  

  • 5. Actinomycin D as rescue therapy in dogs with relapsed or resistant lymphoma: 49 cases (1999--2006).
    Bannink EO; Sauerbrey ML; Mullins MN; Hauptman JG; Obradovich JE
    J Am Vet Med Assoc; 2008 Aug; 233(3):446-51. PubMed ID: 18673031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of temozolomide or dacarbazine in combination with an anthracycline for rescue chemotherapy in dogs with lymphoma.
    Dervisis NG; Dominguez PA; Sarbu L; Newman RG; Cadile CD; Swanson CN; Kitchell BE
    J Am Vet Med Assoc; 2007 Aug; 231(4):563-9. PubMed ID: 17696856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temozolomide alone or in combination with doxorubicin as a rescue agent in 37 cases of canine multicentric lymphoma.
    Treggiari E; Elliott JW; Baines SJ; Blackwood L
    Vet Comp Oncol; 2018 Jun; 16(2):194-201. PubMed ID: 28766920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral melphalan for the treatment of relapsed canine lymphoma.
    Mastromauro ML; Suter SE; Hauck ML; Hess PR
    Vet Comp Oncol; 2018 Mar; 16(1):E123-E129. PubMed ID: 28941072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lomustine (CCNU) for the treatment of resistant lymphoma in dogs.
    Moore AS; London CA; Wood CA; Williams LE; Cotter SM; L'Heureux DA; Frimberger AE
    J Vet Intern Med; 1999; 13(5):395-8. PubMed ID: 10499719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vinblastine as a second rescue for the treatment of canine multicentric lymphoma in 39 cases (2005 to 2014).
    Lenz JA; Robat CS; Stein TJ
    J Small Anim Pract; 2016 Aug; 57(8):429-34. PubMed ID: 27251593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of dacarbazine as a rescue agent for histiocytic sarcoma in dogs.
    Kezer KA; Barber LG; Jennings SH
    Vet Comp Oncol; 2018 Mar; 16(1):77-80. PubMed ID: 28419676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of relapsed canine lymphoma with doxorubicin and dacarbazine.
    Van Vechten M; Helfand SC; Jeglum KA
    J Vet Intern Med; 1990; 4(4):187-91. PubMed ID: 2401965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination chemotherapy with continuous L-asparaginase, lomustine, and prednisone for relapsed canine lymphoma.
    Saba CF; Hafeman SD; Vail DM; Thamm DH
    J Vet Intern Med; 2009; 23(5):1058-63. PubMed ID: 19678892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy with L-asparaginase, lomustine, and prednisone for relapsed or refractory canine lymphoma.
    Saba CF; Thamm DH; Vail DM
    J Vet Intern Med; 2007; 21(1):127-32. PubMed ID: 17338160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexamethasone, melphalan, actinomycin D, cytosine arabinoside (DMAC) protocol for dogs with relapsed lymphoma.
    Alvarez FJ; Kisseberth WC; Gallant SL; Couto CG
    J Vet Intern Med; 2006; 20(5):1178-83. PubMed ID: 17063713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternating Rabacfosadine/Doxorubicin: Efficacy and Tolerability in Naïve Canine Multicentric Lymphoma.
    Thamm DH; Vail DM; Post GS; Fan TM; Phillips BS; Axiak-Bechtel S; Elmslie RS; Klein MK; Ruslander DA
    J Vet Intern Med; 2017 May; 31(3):872-878. PubMed ID: 28370378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lomustine and prednisone as a first-line treatment for dogs with multicentric lymphoma: 17 cases (2004-2005).
    Sauerbrey ML; Mullins MN; Bannink EO; Van Dorp TE; Kaneene JB; Obradovich JE
    J Am Vet Med Assoc; 2007 Jun; 230(12):1866-9. PubMed ID: 17571992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and toxicity of carboplatin and cytarabine chemotherapy for dogs with relapsed or refractory lymphoma (2000-2013).
    Gillem J; Giuffrida M; Krick E
    Vet Comp Oncol; 2017 Jun; 15(2):400-410. PubMed ID: 26463827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent use of rabacfosadine and L-asparaginase for relapsed or refractory multicentric lymphoma in dogs.
    Cawley JR; Wright ZM; Meleo K; Post GS; Clifford CA; Vickery KR; Vail DM; Bergman PJ; Thamm DH
    J Vet Intern Med; 2020 Mar; 34(2):882-889. PubMed ID: 32064697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and adverse event profile of dexamethasone, melphalan, actinomycin D, and cytosine arabinoside (DMAC) chemotherapy in relapsed canine lymphoma.
    Parsons-Doherty M; Poirier VJ; Monteith G
    Can Vet J; 2014 Feb; 55(2):175-80. PubMed ID: 24489398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.